🇺🇸 FDA
Pipeline program

BMN 111 administration via Injector Pen

111-104

Phase 1 other terminated

Quick answer

BMN 111 administration via Injector Pen for Achondroplasia is a Phase 1 program (other) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).

Program details

Company
BIOMARIN PHARMACEUTICAL INC
Indication
Achondroplasia
Phase
Phase 1
Modality
other
Status
terminated

Clinical trials